Changes in Invasive Breast Cancer and Ductal Carcinoma In Situ Rates in Relation to the Decline in Hormone Therapy Use

Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California

(2010) Rochelle R Ereman et al.   BMC PUBLIC HEALTH

Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg

(2009) Patrik Vankrunkelsven et al.   BREAST CANCER RESEARCH AND TREATMENT

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years

(2009) Mats Lambe et al.   BREAST CANCER RESEARCH AND TREATMENT

Screening mammography intervals among postmenopausal hormone therapy users and nonusers

(2009) Tracy Onega et al.   CANCER CAUSES & CONTROL

The impact of changes in hormone therapy on breast cancer incidence in the US population

(2009) Nathan J. Coombs et al.   CANCER CAUSES & CONTROL

The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004

(2009) C. R. Eheman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Rates of Atypical Ductal Hyperplasia Have Declined with Less Use of Postmenopausal Hormone Treatment: Findings from the Breast Cancer Surveillance Consortium

(2009) T. S. Menes et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A 2009 Update on the Treatment of Patients with Hormone Receptor—Positive Breast Cancer

(2009) Susan J. Cleator et al.   Clinical Breast Cancer

Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?

(2009) Donald Maxwell Parkin   EUROPEAN JOURNAL OF CANCER

Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

(2009) Rowan T. Chlebowski et al.   NEW ENGLAND JOURNAL OF MEDICINE